French firm takes control of Lancet Zimbabwe operations
Reading Time: 0 min
France-based multinational Cerba Healthcare has entered into a joint venture agreement with medical services provider Lancet Laboratories for an undisclosed amount in a move that will see it take control of the Zimbabwean unit.
The agreement with South Africa-based Lancet will give Cerba control over a network of more than 100 laboratories previously owned by the firm that operate in 11 African countries including Kenya, Tanzania, Uganda, Rwanda, Botswana, Ghana, Mozambique, Nigeria, Swaziland, Zambia and Zimbabwe.
The labs spread across Africa have over 1,400 employees serving more than 1.3 million patients a year.
Lancet SA will now hold a 49 percent stake in the joint venture while Cerba Healthcare will own 51 percent.
The joint venture, however, does not include operations in South Africa.
Lancet Zimbabwe Clinical Laboratories is a pathologist led practice, managed by Dr C. Muronda (CEO), supported by Consultant Histopathologist Dr R. Makunike Mutasa, Consultant Haematologist Dr T Maboreke and General Manager Mrs G. Ramhewa.
It is a member of the Lancet Group of Laboratories originally founded in South Africa.
Lancet Laboratories in South Africa is an internationally ISO-accredited pathology laboratory which has been in the business for more than 50 years, has more than 100 reference laboratories, more than 250 branch offices in various parts of Africa and more than 80 pathologists specializing in different aspects of pathology available for doctors to seek expert opinion whenever they need.